Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000078

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 8, 2017
Accepted (ET)
Jun 13, 2017 · 1:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 8, 2017P1,000$0.0582A21,144,349D
Common StockJun 8, 2017P1,000$0.0569A21,145,349D
Common StockJun 8, 2017P1,000$0.0579A21,146,349D
Common StockJun 8, 2017P1,000$0.0579A21,147,349D
Common StockJun 8, 2017P1,000$0.0565A21,148,349D
Common StockJun 8, 2017P1,000$0.0569A21,149,349D
Common StockJun 8, 2017P1,000$0.0567A21,150,349D
Common StockJun 8, 2017P1,000$0.0569A21,151,349D
Common StockJun 8, 2017P1,000$0.0569A21,152,349D
Common StockJun 8, 2017P1,000$0.0569A21,153,349D
Common StockJun 8, 2017P1,000$0.0569A21,154,349D
Common StockJun 8, 2017P1,000$0.0569A21,155,349D
Common StockJun 8, 2017P2,000$0.0569A21,157,349D
Common StockJun 8, 2017P1,000$0.0569A21,158,349D
Common StockJun 8, 2017P1,000$0.0568A21,159,349D
Common StockJun 9, 2017P1,000$0.0569A21,160,349D
Common StockJun 9, 2017P1,000$0.0565A21,161,349D
Common StockJun 9, 2017P1,000$0.0563A21,162,349D
Common StockJun 9, 2017P1,000$0.0563A21,163,349D
Common StockJun 9, 2017P1,000$0.053A21,164,349D
Common StockJun 9, 2017P1,000$0.053A21,165,349D
Common StockJun 9, 2017P1,000$0.0535A21,166,349D
Common StockJun 9, 2017P1,000$0.055A21,167,349D
Common StockJun 9, 2017P1,000$0.0567A21,168,349D
Common StockJun 9, 2017P1,000$0.0569A21,169,349D
Common StockJun 9, 2017P1,000$0.057A21,170,349D
Common StockJun 9, 2017P1,000$0.0578A21,171,349D
Common StockJun 9, 2017P1,000$0.0579A21,172,349D
Common StockJun 9, 2017P1,000$0.0596A21,173,349D
Common StockJun 9, 2017P1,000$0.0596A21,174,349D

Table II — derivative securities

No Table II lines on this filing.